These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15046077)

  • 1. Gene symbol: HFE. Disease: Haemochromatosis.
    Bento MC; Ribeiro ML; Relvas L
    Hum Genet; 2004 Mar; 114(4):405. PubMed ID: 15046077
    [No Abstract]   [Full Text] [Related]  

  • 2. Human gene mutations. Gene symbol: HFE. Disease: hereditary haemochromatosis.
    de Villiers JN; Scholtz CL; Hoogendijk CF; Cawood EJ; Kotze MJ
    Hum Genet; 1998 Jan; 102(1):127. PubMed ID: 9490291
    [No Abstract]   [Full Text] [Related]  

  • 3. Compound heterozygous C282Y/Q283P and Q283P/H63D mutations in haemochromatosis.
    van Gammeren A; de Baar E; Schrauwen L; van Wijngaarden P
    Br J Haematol; 2015 Nov; 171(4):650-1. PubMed ID: 25850353
    [No Abstract]   [Full Text] [Related]  

  • 4. [From gene to disease; HFE-mutations in primary haemochromatosis].
    Swinkels DW; Jacobs EM
    Ned Tijdschr Geneeskd; 2003 Apr; 147(14):652-6. PubMed ID: 12712648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HFE gene mutations are extremely rare in Western sub-Saharan Africa.
    Martins R; Picanço I; Nunes B; Romão L; Faustino P
    Ann Hematol; 2005 Oct; 84(10):686-8. PubMed ID: 15834568
    [No Abstract]   [Full Text] [Related]  

  • 6. [Frequency of HFE gene mutations and genotype-phenotype correlations in patients with hereditary hemochromatosis in Switzerland].
    Himmelmann A; Bortoluzzi L; Jansen S; Fehr J
    Schweiz Med Wochenschr; 2000 Aug; 130(31-32):1112-9. PubMed ID: 11008304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemochromatosis, HFE and genetic complexity.
    Risch N
    Nat Genet; 1997 Dec; 17(4):375-6. PubMed ID: 9398831
    [No Abstract]   [Full Text] [Related]  

  • 8. Mutations of the HFE gene among Turkish hereditary hemochromatosis patients.
    Simsek H; Balaban YH; Yilmaz E; Sumer H; Buyukasik Y; Cengiz C; Ozcebe O; Hascelik G; Tatar G
    Ann Hematol; 2005 Oct; 84(10):646-9. PubMed ID: 15871018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results. The European Haemochromatosis Consortium.
    Merryweather-Clarke AT; Pointon JJ; Shearman JD; Robson KJ; Jouanolle AM; Mosser A; David V; Le Gall JY; Halsall DJ; Elsey TS; Kelly A; Cox TM; Clare M; Bomford A; Vandwalle JL; Rochette J; Borot N; Coppin H; Roth MP; Ryan E; Crowe J; Totaro A; Gasparini P; Roetto A; Walker AP
    Nat Genet; 1999 Nov; 23(3):271. PubMed ID: 10545942
    [No Abstract]   [Full Text] [Related]  

  • 10. The HFE Cys282Tyr mutation as a necessary but not sufficient cause of clinical hereditary hemochromatosis.
    Beutler E
    Blood; 2003 May; 101(9):3347-50. PubMed ID: 12707220
    [No Abstract]   [Full Text] [Related]  

  • 11. No age-related decrease in frequency of heterozygotes for the HFE C282Y haemochromatosis mutation.
    Waalen J; Beutler E
    J Hepatol; 2004 Jun; 40(6):1044; author reply 1044-5. PubMed ID: 15158353
    [No Abstract]   [Full Text] [Related]  

  • 12. The geography of HFE mutations: molecular diagnosis of haemochromatosis and the globalization of genetic testing.
    Salto-Tellez M; Siew-Chuan Koay E
    Eur J Hum Genet; 2004 Nov; 12(11):877-8. PubMed ID: 15340365
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemochromatosis protein HFE C282Y conformational considerations.
    Lawless MW
    Hepatology; 2010 Jul; 52(1):398-9. PubMed ID: 20232489
    [No Abstract]   [Full Text] [Related]  

  • 14. Epidemiologic study on HFE C282Y mutation in Azerbaijan.
    Jafarov T; Zhu H; Finnell R; Kulieva S
    Eur J Haematol; 2005 Feb; 74(2):180-1. PubMed ID: 15654913
    [No Abstract]   [Full Text] [Related]  

  • 15. Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results.
    Noll WW; Belloni DR; Stenzel TT; Grody WW
    Nat Genet; 1999 Nov; 23(3):271-2. PubMed ID: 10610176
    [No Abstract]   [Full Text] [Related]  

  • 16. [Screening for HFE C282Y mutation at birth?].
    Rochette J; Cadet E
    Rev Med Interne; 2006 Jan; 27(1):1-4. PubMed ID: 16337066
    [No Abstract]   [Full Text] [Related]  

  • 17. Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results.
    Gomez PS; Parks S; Ries R; Tran TC; Gomez PF; Press RD
    Nat Genet; 1999 Nov; 23(3):272. PubMed ID: 10545944
    [No Abstract]   [Full Text] [Related]  

  • 18. Testing families with HFE-related hereditary haemochromatosis.
    Siezenga MA; Rasp E; Wijermans PW
    Neth J Med; 2004 May; 62(5):156-9. PubMed ID: 15366698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the second HFE gross deletion highlights the potential importance of Alu-mediated recombination in haemochromatosis.
    Ka C; Chen JM; Gourlaouen I; Quemener S; Ronsin C; Massonnet S; Thérond JP; Férec C; Le Gac G
    Br J Haematol; 2015 Mar; 168(5):759-62. PubMed ID: 25284364
    [No Abstract]   [Full Text] [Related]  

  • 20. Frequency of the C282Y mutation of hemochromatosis in five French populations.
    Mercier G; Bathelier C; Lucotte G
    Blood Cells Mol Dis; 1998 Jun; 24(2):165-6. PubMed ID: 9642097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.